thomas pryor is glaxosmithkline's chief global health officer. he explains why it has taken so long to develop the vaccine. >> vaccines are not always the same when it comes to development. you have viruses. you have bacteria, and the cause of malaria is a parasite. it is extremely to develop vaccines against parasites. several researchers have tried to do it, and now we have the first malaria vaccine, which was recommended today. i think eradication is some time away, but the combination of bed nets and in this vaccine and other vaccines in the future, we will bring the malaria burden of disease substantially down in africa. for the time being, we have a new tool in our toolbox, and as soon it is implemented, i'm sure we will see a significant impact. lauren: antonio guterres has urged ethiopia's government to allow the world body to deliver humanitarian aid to millions in the countries north. during a security council meeting, he called on ethiopia's leaders to allow unrestricted movement of desperately needed fuel and humanitarian supplies int

glaxosmithkline have been working on this particular vaccine since the 1980's. people have been wondering what took so long. >> it is importa to recognize maria is not a virus like covid nor a bacteria. it is a parasite. it changes throughout its lifecycle. it has been with us for millennia, probably since the origins of humanity, learning how to avoid our immune system. this is really a landmark. tom: you did say it is not the perfect vaccine. what is not right about it? >> the efficacy of the vaccine is probably around 30% to 40%. that is a significant, massive impact when you are rolling it t to a community of -- i think you said a quarter of a billion are exposed each year. it is not like we are used to with the covid or something, but that does not mean it will not be a massive impact on global health for children in africa. tom: it seems like it is going to save millions of lives, doesn't it? >> over time, for sure. initially, it will be tens of thousands, but so many people died over the eons from malaria that the impact will be felt quite soon. tom: let'

glaxosmithkline said to be drawing some interest for its consumer-products unit.uld be a $50 billion plus deal, basically a who's who of private equity firms said to be kicking the tires, including kkr, carlyle, and a few others. fastenal shares slightly down. they talked about cost with regards to transportation, wages, etc., but you know what they also talked about? covid supplies. this was a huge driver of their best in us -- their business. that was down 40%. tom: i need to go back to glaxo because to me, glaxo has been a 10 year train wreck. mi wrong on that? romaine: i am not going to use the word train wreck, but a lot of activist investors have been circling for this. they have called of the spinoff -- called for the spinoff of a lot of businesses. it has not been in outperformer, that is for sure. flip up the board. i will give you a couple of interesting underperformers. how about this? mgm resorts getting an upgrade today. the price target doubling. saying it is a cleaner, leaner company. i don't know if you are a cable tv subscriber, but they have been

reporter: in clinical trials, the vaccine, developed by the british pharmaceutical giant glaxosmithklines shown to prevent 4 in 10 cases of malaria, leading to a 30% reduction in severe cases. spread by mosquitoes, the parasite invades and destroys red cells. while drugs have helped reduce the prevalence of the disease, it killed more than 400,000 people in 2019, nearly all of them in sub-saharan africa. more than half of those who died were children under the age of 5. the who says the job can be used alongside other prevention methods, such as insecticide methods. >> the malaria parasite is a formidable foe, and while we are excited by this development, major battles remain. reporter: among them, producing and funding the vaccine. the efficacy of the jab starts to fade after a few months. some experts already? there is widespread rollout is a worthwhile investment in countries that have many other health care and political problems. mark: so it seems like this is good news. let's get more analysis. our guest is the head of immigration and vaccines at the w.h.o. joining us life, good ev

scientists say the drug from glaxosmithkline could have major impact, even though it's 30% effective and protection fades in months. but they point out malaria kills nearly half a million people every year. more than 260,000 of them children under 5. they say the vaccine will save many. >>> when we come back here tonight, authorities in the gabby petito case and the possible sightings of brian laundrie. the one state with nearly a dozen reported sightings. >>> and then the major crane collapse in chicago. the images coming in right now. i'm not getting through the pandemic just to end up with the flu. i asked for fluzone high-dose quadrivalent. it's the #1-used flu vaccine for people 65 and older. fluzone high-dose quadrivalent is the only vaccine approved by the fda for superior flu protection in adults 65+. i'm not letting my guard down. fluzone high-dose quadrivalent isn't for people who've had a severe allergic reaction to any flu vaccine or vaccine component, including eggs or egg products. tell your health care professional if you've ever experienced severe muscle weakness afte

drugs and cures and diseases that are out there with that data so they're a fast track for a glaxosmithkline to be successful in the long run so it's a potentially i see it as a $300 market cap company today and could be in 10 years as much or more than glaxosmithkline. that's one i really like. >> give us the other new pick today. >> open door technologies. i talked about zillow this year when i was on with you and been the worst call in terms of stock performance and still own it but the big reason is it's down is i buying process comes under question and open door was the one that pioneered the whole buying process to type in the house and open door makes you an offer for the house if you want cash right away for it they'll do that. zillow was so dismayed by the success that they felt they had to get into the business and the future and i do agree with that. but then when the growth stocks went out of favor the open door stock went down from $39 to $13. it is trading at one times next year's revenues. i think it will go back to the historical high and then a couple years from now could be

we just had a randomized glaxosmithkline antibody, there was an 85% risk reduction in hospitalization been eu a since may and can be used in children to age 12. laura: thank you. what am i doing on fox nation? the last bite will tell you coming up. - look, this isn't my first rodeo, and let me tell you something. i wouldn't be here, if i thought reverse mortgages took advantage of any american senior or worse, that it was some way to take your home. it's just a loan designed for older homeowners and it's helped over a million americans. a reverse mortgage loan isn't some kind of trick to take your home. it's a loan, like any other. big difference is, how you pay it back. - find out how reverse mortgages really work with aag's free, no obligation, reverse mortgage guide. eliminate monthly mortgage payments, pay bills, medical costs, and more. call now and get your free info kit. - other mortgages are paid each month, but with a reverse mortgage, you can pay whatever you can when it works for you. or you can wait and pay it off in one lump sum when you leave your home. - discover the op

. >>> and pharmaceutical giant glaxosmithkline is up 1.5% it's firm on track to sell its health unitend of next year $50 billion or more. unit brands include advil and sensadine. >>> and cloud season is upon us, google conference kicking off in less than an hour. and ceo speaks at noon more ahead for microsoft and cloud getting big contracts. the next guest is out with the cloud tracker analysis of the largest cloud conference piper sandler. first of all, the third place hyper skill right now. sort of has a reputation of being a unit with good technology google cloud, that is but really not great go-to-market, as far as solving problems for the user. is your sense that enterprise engagement has gotten better for google, that it's really growing its ecosystem and ability to compete here, or no? >> 100%. i think we need to realize it takes about a decade to create a $10 billion cloud infrastructure business i think pk has done a phenomenal job, pk 2000, very focused go-to-market effort that has changed their success on the cloud business for sure. and now business scaled, and continuin

glaxosmithkline is preparing to spin off its consumer unit.as learned a number of private equity firms are interested in what could be a $54 billion deal. among them, kkr, blackstone, and carlyle group. the glaxo units also attract some of the world's biggest pharmaceutical and consumer goods companies. in the u.k., a parliament tree report found that boris johnson's government made serious mistakes in the early handling of the coronavirus pandemic erie lawmakers say that imposing a full lockdown more quickly would have saved lives. the european union drew record demand for its debut green bonds. there was more than one under $56 billion in orders today for a sale of almost $40 billion of securities. the money will be used by you nations for energy efficiency, clean energy, and climate change at a patient's. -- clement change expectations. -- climate change expectations. global news 24 hours a day, on air and on bloomberg quicktake, powered by more than 2700 journalists and analysts in more than 120 countries. i'm laura wright. this is bloombe

it's made by glaxosmithkline. it's not perfect. it is moderately effective. it's not 100% effective. you have to get multiple doses which is it a pain. it is the first vaccine we have ever had. it is effective enough that they think it will save the lives of at least tens of thousands of children every year. as soon as it's put into place. the world health organization just approved it days ago. the pilot programs that tested it in malawi and ghana and kenya are seen as really big successes. they're going to build on those. thanks to researchers and scientists and drug development, human kind will start to throw our first ever punches that is killing kids by hundreds of thousands for all the years that manufacture us have been on earth. which is something. and this is something farther off but also good. you know the kind of vaccine that pfizer and moderna have made against covid, the same mrna technology they used to be able to make those so quickly? well, next month, they're starting clinical trials for a new candidate for hiv vaccine. hiv the virus that ca

it's made by glaxosmithkline, and's not perfect, it's moderately effective, it's not 100 percent effectiveywhere near. you have to get multiple doses, of it which is a pain. but it is the first vaccine, we have ever had, that is effective enough that it will literally save the lives of at least tens of thousands of children every year. as soon as it's put into place. the world health organization just approved days ago. the pilot programs that tested and ghana and malawi, and in kenya, our seen is really big successes, so they'll build on those. and things to research scientists and drug development, humankind will now start to throw our first ever punches at something that has been killing kids by the hundreds of thousands, for all the years that any of us have been on earth. which is something. and, this is something that's further off, but also good, you know they kind of vaccine that pfizer and moderna have made against, guava this mrna technology that they used to be able to make the covid vaccine so quickly, well next month, they are starting clinical trials for a new candidate for a

glaxosmithkline is said to be joining by off interest in what could be the biggest private equity takeoverrd. the business could be valued at $54 million or more. cbc r is among the potential suitors. shery: take a look at the commodities space. oil still above that $80 a barrel level. we saw pressure on copper prices given the imf just cut their growth forecast for the global economy. coffee soaring to a seven-year high. surprise concerns whether it bad weather or shipping disruptions. perhaps a bullish sign when it comes to prices on wheat because we did get the agricultural supply and size smaller than expected supply. i know that was happening with avocado very closely. haidi: avocado glut slumping australia. this is a fruit or vegetable -- i know it's controversial what you define it as. it is close to australian hearts. that -- there's been supermarkets awash with supply of avocados, like a dollar each. as i know you know how expensive avocados used to be when we bought them in hong kong. shery: whether it's veggie or fruit, i'm always happy to have avocado on the table. let's turn t

that's according to the world health organization, which today endorsed a new vaccine made by glaxosmithkline poor countries the head of the global malaria prom program at the w.h.o. calling it an historic event. >>> an 18-year-old now in custody after police say he ran from the scene happened in timberville high school in arlington, texas police say one student is now critical, another in good condition. two other victims escaped with minor injuries police say the suspect turned himself in after hiring a lawyer he had been charged with three counts of aggravated assault of a deadly weapon. >>> and closing arguments today in the first trial of the so-called varsity blues college admissions scandal on trial today two men who prosecutors say paid bribes so that a counselor could get their kids into usc. as athletic recruits even though they didn't play any sports the defendants say they thought that they were making legitimate donations. the operation ensnared dozens of wealthy people, including lori loughlin of "full house" and felicity huffman of "desperate housewives." they both pleaded guil

first developed in 1987 by glaxosmithkline it is the first malaria vaccine to be authorized.g parasitic disease, more than 260,000 alone african children under age o 5, scientists say the vaccine could still have a major impact. >>> coming up, our next guest is calling on senator chuck grassley to apologize for comments the senator made to a korean-american judge. we'll play that for you next on "morning joe." ♪ ♪ ♪ hey google. ♪ ♪ ♪ ♪ ♪ ♪ bipolar depression. it made me feel like i was trapped in a fog. this is art inspired by real stories of people living with bipolar depression. i just couldn't find my way out of it. the lows of bipolar depression can take you to a dark place... ...and be hard to manage. latuda could make a real difference in your symptoms. latuda was proven to significantly reduce bipolar depression symptoms and in clinical studies, had no substantial impact on weight. this is where i want to be. latuda is not for everyone. call your doctor about unusual mood changes, behaviors, or suicidal thoughts. antidepressants can increase these in children, teens, a